Search Results

Displaying Results 9676-9700 of 28380 "'B'"

Jun 08, 2026, 08:30 ET Touchstone Investments Chooses Bloomberg Equity Indices to Support Active Strategies

creation. Flagship equity benchmarks include the World, Developed Markets and Emerging Markets Large & Mid Cap Indices, as well as the Bloomberg 500 ® (B500) Index.For more information on Bloomberg's equity indices and custom benchmark capabilities, visit

More news about: Bloomberg L.P.


Jun 08, 2026, 08:07 ET J.S. Held Earns Multiple Rankings in Inaugural Legal 500 Disputes Services Guide

any other public accounting services. J.S. Held is not a law firm and does not provide legal advice. Securities offered through PM Securities, LLC, d/b/a Phoenix IB or Ocean Tomo Investments, a part of J.S. Held, member FINRA/SIPC. All rights reserved.ContactKristi L. Stathis | Global

More news about: J.S. Held


Jun 08, 2026, 08:07 ET J.S. Held Earns Multiple Rankings in Inaugural Legal 500 Disputes Services Guide

any other public accounting services. J.S. Held is not a law firm and does not provide legal advice. Securities offered through PM Securities, LLC, d/b/a Phoenix IB or Ocean Tomo Investments, a part of J.S. Held, member FINRA/SIPC. All rights reserved.ContactKristi L. Stathis | Global

More news about: J.S. Held


Jun 08, 2026, 08:04 ET TransCode Therapeutics to Host R&D Webcast on June 18, 2026

on treating advanced malignancy.  The Company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic tumors that overexpress microRNA-10b, a unique, well-documented biomarker of metastasis. In addition, TransCode has a portfolio of other first-in-class therapeutic candidates designed

More news about: TransCode Therapeutics, Inc.


Jun 08, 2026, 08:00 ET AbbVie Presents New Data Across Its Blood Cancer Portfolio at EHA 2026

Etentamig in patients with relapsed/refractory multiple myeloma (RRMM) with prior exposure to B-cell maturation antigen (BCMA)-targeted therapyResults from Arm B of the MONVISO study (

More news about: AbbVie


Jun 08, 2026, 08:00 ET AbbVie Presents New Data Across Its Blood Cancer Portfolio at EHA 2026

Etentamig in patients with relapsed/refractory multiple myeloma (RRMM) with prior exposure to B-cell maturation antigen (BCMA)-targeted therapyResults from Arm B of the MONVISO study (

More news about: AbbVie


Jun 08, 2026, 08:00 ET Trillion Labs is Developing Industrial World Models for AI Factories, built with NVIDIA Omniverse and NVIDIA Nemotron

behind NAVER's HyperCLOVA X. Within a year of its founding, the company developed and open-sourced a full lineup of large language models (LLMs)—including 7B, 21B, and 70B parameter models—from scratch.Since then, Trillion Labs has expanded beyond language models, introducing a vision-language model (VLM),

More news about: Trillion Labs


Jun 08, 2026, 08:00 ET Reco Expands Executive Team and Global Footprint to Accelerate Leadership in Enterprise AI Agent Security

Development. Twining joins from FireMon, where as Senior Vice President of Sales Americas she drove and closed enterprise cybersecurity deals across the $1B to $3B segment. At Reco, she will own the full Americas sales motion with responsibility for pipeline growth, enterprise close, and expanding the company's

More news about: Reco


Jun 08, 2026, 08:00 ET Eleven Acquires Stella Networks, Bringing Automated Network Compliance to Hospitality

networks — without requiring network engineers to access active equipment directly. The platform is SOC 2 compliant and holds U.S. Patent 12,250,124 B2. Stella's technology has already been adopted by leading hospitality organizations and has undergone extensive security, compliance, and operational validation.

More news about: Eleven


Jun 08, 2026, 08:00 ET Apnimed Appoints Experienced Pharmaceutical Executive Kevin R. Lind as Chief Executive Officer to Implement Next Phase of Growth Strategy

prior CEO, commercial, financial and capital markets experience, including leading Longboard Pharmaceuticals to an acquisition by H. Lundbeck A/S for $2.6B, to support Apnimed's evolution to a potential commercial-stage companyPaul Sekhri joins Apnimed's board as Chair of the Board of Directors,

More news about: Apnimed, Inc.


Jun 08, 2026, 08:00 ET InvestNext Opens Early Access to InvestNext MCP, Giving GPs Direct Access to Their Investor Data Inside the AI Tools They Already Use

InvestNext, the real estate capital management platform that hosts over $23B in funds under management for more than 1,600 GPs and their 90,000 investors, today announced the

More news about: InvestNext


Jun 08, 2026, 07:00 ET Protego Biopharma Appoints Jae B. Kim, MD, as Chief Medical Officer

clinical-stage biotechnology company focused on developing small-molecule drugs that target protein misfolding diseases, today announced the appointment of Jae B. Kim, MD, as its Chief Medical Officer (CMO). Dr. Kim joins Protego after serving as Chief Medical Officer of Septerna since 2024.

More news about: Protego Biopharma


Jun 08, 2026, 07:00 ET BMO Economics: Host Cities to Anchor up to $81B Soccer-Powered Economic Boost for U.S.

content:https://www.prnewswire.com/news-releases/bmo-economics-host-cities-to-anchor-up-to-81b-soccer-powered-economic-boost-for-us-302793026.htmlSOURCE

More news about: BMO Financial Group


Jun 08, 2026, 07:00 ET Centage CEO Paul Lynch Launches The CFO Review, a Podcast for Finance Leaders Ready to Earn Their Seat at the Table

Karl Pichler, former CFO of Rackspace, the leader who guided the company from $80M to $2.1B in revenue, took it public in 2008, and navigated a $4.5B leveraged buyout from Apollo Capital. It's the kind of career story most finance professionals only read about in press releases.

More news about: Centage Corporation


Jun 08, 2026, 06:59 ET Electric Commercial Vehicle Market worth $197.55 billion by 2033 | MarketsandMarkets™

alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.Today, 80%

More news about: MarketsandMarkets


Jun 08, 2026, 06:54 ET 'Nurturing Nature Together': Manipal Hospital Malleshwaram and Children with Special Needs Plant Saplings for World Environment Day

alongside Mr. Abdul Hafeez, Hospital Director, Dr. G K Prakash, Consultant - Nephrology & Transplant Physician, and Dr. Sowbhagya B, Consultant - OBG, Manipal Hospital Malleshwaram, to support this cause of environmental stewardship.Highlighting that conservation is a daily

More news about: Manipal Hospitals


Jun 08, 2026, 06:40 ET Liquid-applied Membrane Market worth $35.47 billion by 2031 - Exclusive Report by MarketsandMarkets™

alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.Today, 80%

More news about: MarketsandMarkets


Jun 08, 2026, 06:30 ET QUANTUM SPACE, A LEADING SPACE DEFENSE AND ORBITAL MOBILITY COMPANY, TO GO PUBLIC VIA MERGER WITH INFLECTION POINT ACQUISITION CORP. VI

eligibility under the Space Force's $6.2B Andromeda IDIQ vehicle Transaction includes an initial $300M PIPE investment anchored by Inflection Point; pre-money equity value of approximately $600M and a post-transaction equity value of approximately $1.2B Parties to host a virtual

More news about: Quantum Space


Jun 08, 2026, 06:00 ET HONEYWELL REAFFIRMS 2026 OUTLOOK AHEAD OF HONEYWELL AEROSPACE SPIN-OFF; INITIATES 2026 OUTLOOK FOR HONEYWELL TECHNOLOGIES

$38.8B - $39.8B$19.9B - $20.2B$10.1B - $10.3B

More news about: Honeywell


Jun 08, 2026, 06:00 ET Gamehaus Holdings Inc. Announces Unaudited Financial Results for the Third Quarter of Fiscal 2026 Ended March 31, 2026

transactions, in block trades, and/or through other legally permissible means, including through the use of trading plans, intended to qualify under Rule 10b-18 under the Securities Exchange Act of 1934, as amended, in accordance with applicable securities laws and other restrictions and subject to market conditions

More news about: Gamehaus Holdings Inc.


Jun 08, 2026, 05:01 ET Kali Therapeutics Announces Poster Presentation of KT209, a Novel CD19 x CD20 x CD3 Trispecific Antibody, at the EHA 2026 Annual Congress

KT209 is a novel trispecific antibody engineered to co-engage CD19, CD20, and CD3, redirecting endogenous T cells to achieve deep B-cell depletion. While traditional bispecific T-cell engagers (TCEs) targeting a single antigen face challenges with treatment failure due to antigen escape

More news about: Kali Therapeutics


Jun 08, 2026, 05:00 ET Foresee's Oral ALDH2 Activator, Mirivadelgat to Enter Clinical Testing in Parkinson's Disease in the SLEIPNIR Phase 2a Platform Trial

Revenues in the US and European markets are set to increase the most. The market is mainly comprised of levodopa-based therapies, COMT inhibitors, MAO-B inhibitors, and dopamine agonists, many of which are approved for patients with "off" episodes (resulting from long-term use of levodopa), which

More news about: Foresee Pharmaceuticals Co., Ltd.


Jun 08, 2026, 04:30 ET 2026 ADA | Innovent Presents Multiple Clinical and Preclinical Results of Next-Generation Obesity & Metabolic Pipeline

Directors and the employees of the Company assume (a) no obligation to correct or update the forward-looking statements contained in this site; and (b) no liability in the event that any of the forward-looking statements does not materialise or turn out to be incorrect.

More news about: Innovent Biologics


Jun 08, 2026, 03:52 ET 아리비아와 크리스플라이어, 마일리지를 활용한 크루즈 예약 서비스 출시를 위해 파트너십 확대

multimedia:https://www.prnewswire.com/kr/news-releases/uC544uB9ACuBE44uC544uC640u002DuD06CuB9ACuC2A4uD50CuB77CuC774uC5B4u002Cu002DuB9C8uC77CuB9ACuC9C0uB97Cu002DuD65CuC6A9uD55Cu002DuD06CuB8E8uC988-302793811.htmlSOURCE

More news about: arrivia


Jun 08, 2026, 03:50 ET PHR Investors Have Opportunity to Lead Phreesia, Inc. Securities Fraud Lawsuit with the Schall Law Firm

PHR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

More news about: The Schall Law Firm


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.